Analyst Overvalued Stocks on the TSX July 2024

July 30, 2024

Analyst Overvalued

Companies on this list are considered overvalued based on the analyst consensus. This means that the average analyst target price is less than the close price.

TSX Venture Exchange

The TSX Venture Exchange is a stock exchange headquartered in Calgary, Alberta, Canada. It is an exchange for the securities of early-stage businesses.

About the Data

This table includes the close price and analyst target price mean from most recent available data. The fiscal year indicates the year for the analyst target price, as the target may not always be for the current year. The number of estimates indicates the number of analyst targets used to calculate the target price mean.

How do you use this table?

Analysts believe that the companies on this list will see the close price drop to their target price mean by the target year indicated. Companies with a large analyst following or large difference between close price and target price are particularly interesting to investigate further. This becomes a starting point for further analysis to understand why these companies are overvalued. Stocks in this category are generally sold to preserve capital.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose PriceTarget Price MeanTarget YearNumber of EstimatesCurrency
RX Biosyent Inc 10.10 9.65 2024 1 CAD
QIS Quorum Information Technologies Inc 0.88 0.85 2024 1 CAD
IFX Imaflex Inc 1.04 1.00 2024 1 CAD
All data provided as at market close July 29, 2024.

Company Details

Biosyent Inc

RX:TSX-V

Close Price

10.10

Target Price Mean

9.65

Target Year

2024

Target Price # Estimates

1

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.

Access the stockcalc valuation


Quorum Information Technologies Inc

QIS:TSX-V

Close Price

0.88

Target Price Mean

0.85

Target Year

2024

Target Price # Estimates

1

Quorum Information Technologies Inc is an information technology company engaged in the automotive retail business. It develops, markets, implements, and supports its software products, XSELLERATOR, a Dealership Management System for the automotive market; Autovance Desk, Menu and MyDeal, a sales desking, menuing, and digital retailing system; DealerMine Service and Sales Customer Relationship Management (CRM system and Business Development Centre (BDC); and Quorum Advantage showroom system.

Access the stockcalc valuation


Imaflex Inc

IFX:TSX-V

Close Price

1.04

Target Price Mean

1.00

Target Year

2024

Target Price # Estimates

1

Imaflex Inc is focused on the manufacture and sale of products for the flexible packaging industry, including polyethylene film and bags, as well as the metallization of plastic film for the agriculture and packaging industries. It manufactures and sells industrial bags using recycled material, including garbage bags, compostable bags, gaylord bags and bags on rolls. Geographically, it operates in Canada, United States and Other countries.

Access the stockcalc valuation


Biosyent and Quorum Information Tech are among the most overvalued TSX stocks this month. See the most overvalued companies on the blog: https://www.stockcalc.com/Blog/analyst-overvalued-stocks-tsx-july-2024
Biosyent $RX and Quorum Information Tech $QIS on the #TSX among the most overvalued this month. See the full list of overvalued companies: https://www.stockcalc.com/Blog/analyst-overvalued-stocks-tsx-july-2024
Biosyent and Quorum Information Tech are among the most overvalued TSX stocks this month. See the most overvalued companies on the blog: https://www.stockcalc.com/Blog/analyst-overvalued-stocks-tsx-july-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.